A Maraviroc-Resistant HIV-1 with Narrow Cross-Resistance to Other CCR5 Antagonists Depends on both N-Terminal and Extracellular Loop Domains of Drug-Bound CCR5

CCR5 antagonists inhibit HIV entry by binding to a coreceptor and inducing changes in the extracellular loops (ECLs) of CCR5. In this study, we analyzed viruses from 11 treatment-experienced patients who experienced virologic failure on treatment regimens containing the CCR5 antagonist maraviroc (MV...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Tilton, John C., Wilen, Craig B., Didigu, Chukwuka A., Sinha, Rohini, Harrison, Jessamina E., Agrawal-Gamse, Caroline, Henning, Elizabeth A., Bushman, Frederick D., Martin, Jeffrey N., Deeks, Steven G., Doms, Robert W.
Format: Artigo
Idioma:Inglês
Publicat: American Society for Microbiology (ASM) 2010
Matèries:
Vaccines and Antiviral Agents
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2950574/
https://ncbi.nlm.nih.gov/pubmed/20702642
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JVI.01109-10
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars